Diagnostic utility of beta defensin 2 and LL-37 for the differenciation between complicated and non-complicated infectious pleural effusions Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Analysis of amylase rich pleural effusions Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Diagnostic values of inflammation biomarkers in pleural effusions (PE) Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015
Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
Infectious pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204 Year: 2002
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Elevation of serum napsin A levels in patients with hypersensitive pneumonia Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013
Molecular assay for tuberculous pleural effusion Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016
Diagnostic value of pleural fluid adenosine deaminase level in patient with tuberculous pleurisy Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
Decreasing incidence of parapneumonic pleural effusions (PPE) in children Source: International Congress 2016 – Paediatric respiratory infections Year: 2016
Cryptogenic organizing pneumonia- IL1-β, IL-6, IL-8, and TGF- β concentrations in serum in patients treated with clarithromycin Source: International Congress 2016 – Clinical aspects of ILD Year: 2016
Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013